Patients’ self-reported adherence to capecitabine on XELOX treatment in metastatic colorectal cancer: findings from a retrospective cohort analysis

Patients’ self-reported adherence to capecitabine on XELOX treatment in metastatic colorectal cancer: findings from a retrospective cohort analysis

Kazuyoshi Kawakami,1 Eri Nakamoto,1 Takashi Yokokawa,1 Kazuo Sugita,1 Yutarou Mae,1 Akane Hagino,1 Mitsukuni Suenaga,2 Nobuyuki Mizunuma,2 Sayaka Oniyama,3 Yoshiaki Machida,3 Toshiharu Yamaguchi,2 Toshihiro Hama1 1Department of Pharmacy, 2Gastroenterology Center, Cancer Institute Hospital, Japanese...

Full description

Bibliographic Details
Main Authors: Kawakami K, Nakamoto E, Yokokawa T, Sugita K, Mae Y, Hagino A, Suenaga M, Mizunuma N, Oniyama S, Machida Y, Yamaguchi T, Hama T
Format: Article
Language:English
Published: Dove Medical Press 2015-04-01
Series:Patient Preference and Adherence
Online Access:http://www.dovepress.com/patientsrsquo-self-reported-adherence-to-capecitabine-on-xelox-treatme-peer-reviewed-article-PPA

Internet

http://www.dovepress.com/patientsrsquo-self-reported-adherence-to-capecitabine-on-xelox-treatme-peer-reviewed-article-PPA

Similar Items